Anxin securities released a research report on April 25, saying that it maintained the buying rating of Bloomage Biotechnology Corporation Limited(688363) ( Bloomage Biotechnology Corporation Limited(688363) .sh, latest price: 116.3 yuan). The reasons for rating mainly include: 1) the cost ratio decreased significantly month on month, and the profit margin improved month on month; 2) Tiktok channel has been transformed, and functional cosmetics have driven revenue growth. Risk tip: covid-19 epidemic continues to deteriorate, industry competition intensifies, and the effect of new products on the market is less than expected.
AI comments: Bloomage Biotechnology Corporation Limited(688363) in the past month, it has received 11 research reports from securities companies, bought 9 and increased its holdings of 2. The average target price is 140.28 yuan, which is 23.98 yuan higher than the latest price of 116.3 yuan, and the average target price increases by 20.62%.
